Clinical Trials Directory

Trials / Completed

CompletedNCT01194713

Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics

Losing Sleep Over Alzheimer's Disease? Effects of Sleep Deprivation on Cerebrospinal Fluid Amyloid-beta Dynamics

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
University Medical Center Nijmegen · Academic / Other
Sex
Male
Age
40 Years – 60 Years
Healthy volunteers
Accepted

Summary

Introduction: Alzheimer's disease (AD) is characterized by neurodegeneration of the brain in the form of neurofibrillary tangles and plaques containing the amyloid-beta protein (Abeta). Recent animal studies have shown that extended wakefulness is associated with increased production of these Abeta proteins and that sleep leads to a marked fall in their production. Aim: The investigators aim to distinguish a similar effect of sleep disturbance on cerebrospinal fluid (CSF) Abeta levels in humans, which may point out sleep disturbance as an important factor in AD development. Methods: a study in 26 healthy male volunteers, measuring CSF Abeta levels during a sleep deprivation night and before and after a control night with unrestricted sleep. Expected results: The investigators expect sleep deprivation to lead to an increase in CSF Abeta levels, as compared to the levels in the control night.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSleep deprivationsubjects will undergo one night of full sleep deprivation

Timeline

Start date
2011-03-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2010-09-03
Last updated
2014-05-13

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01194713. Inclusion in this directory is not an endorsement.